BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7542809)

  • 1. Tacrolimus analysis: a comparison of different methods and matrices.
    Warty V; Zuckerman S; Venkataramanan R; Lever J; Chao J; Mckaveney T; Fung J; Starzl T
    Ther Drug Monit; 1995 Apr; 17(2):159-67. PubMed ID: 7542809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FK506 measurement: comparison of different analytical methods.
    Warty V; Zuckerman S; Venkataramanan R; Lever J; Fung J; Starzl T
    Ther Drug Monit; 1993 Jun; 15(3):204-8. PubMed ID: 7687389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatography-tandem mass spectrometry as a reference for analysis of tacrolimus to assess two immunoassays in patients with liver and renal transplants.
    Salm P; Taylor PJ; Clark A; Balderson GA; Grygotis A; Norris RL; Lynch SV; Shaw LM; Pond SM
    Ther Drug Monit; 1997 Dec; 19(6):694-700. PubMed ID: 9421113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients.
    Venkataramanan R; Shaw LM; Sarkozi L; Mullins R; Pirsch J; MacFarlane G; Scheller D; Ersfeld D; Frick M; Fitzsimmons WE; Virji M; Jain A; Brayman KL; Shaked A
    J Clin Pharmacol; 2001 May; 41(5):542-51. PubMed ID: 11361051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Pro-Trac tacrolimus monoclonal whole-blood enzyme-linked immunosorbent assay for monitoring of tacrolimus levels in patients after kidney, heart, and liver transplantation.
    Winkler M; Christians U; Baumann J; Gonschior AK; Wonigeit K; Pichlmayr R
    Ther Drug Monit; 1996 Dec; 18(6):640-6. PubMed ID: 8946659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of whole blood tacrolimus concentrations in liver transplant patients exhibiting impaired liver function.
    MacFarlane GD; Shaw LM; Venkataramanan R; Mullins R; Scheller DG; Ersfeld DL
    Ther Drug Monit; 1999 Dec; 21(6):585-92. PubMed ID: 10604816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of an ELISA and an LC/MS/MS method for measuring tacrolimus concentrations and making dosage decisions in transplant recipients.
    Staatz CE; Taylor PJ; Tett SE
    Ther Drug Monit; 2002 Oct; 24(5):607-15. PubMed ID: 12352932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pitfalls in monitoring tacrolimus (FK 506).
    Braun F; Schütz E; Christians U; Lorf T; Schiffmann JH; Armstrong VW; Schröter W; Sewing KF; Oellerich M; Ringe B
    Ther Drug Monit; 1997 Dec; 19(6):628-31. PubMed ID: 9421102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is microparticle enzyme-linked immunoassay (MEIA) reliable for use in tacrolimus TDM? Comparison of MEIA to liquid chromatography with mass spectrometric detection using longitudinal trough samples from transplant recipients.
    Napoli KL
    Ther Drug Monit; 2006 Aug; 28(4):491-504. PubMed ID: 16885716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of tacrolimus (FK506) in whole blood liver transplant recipients by PRO-TRAC enzyme-linked immunosorbent assay and microparticle enzyme immunoassay IMX methods.
    Brunet M; Pou L; Torra M; López R; Rodamilans M; Corbella J
    Ther Drug Monit; 1996 Dec; 18(6):706-9. PubMed ID: 8946669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
    Westley IS; Taylor PJ; Salm P; Morris RG
    Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FK506 (tacrolimus) and its immunoreactive metabolites in whole blood of liver transplant patients and subjects with mild hepatic dysfunction.
    Tokunaga Y; Alak AM
    Pharm Res; 1996 Jan; 13(1):137-40. PubMed ID: 8668663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified pentamer formation assay for measurement of tacrolimus and its active metabolites: comparison with liquid chromatography-tandem mass spectrometry and microparticle enzyme-linked immunoassay (MEIA-II).
    Armstrong VW; Schuetz E; Zhang Q; Groothuisen S; Scholz C; Shipkova M; Aboleneen H; Oellerich M
    Clin Chem; 1998 Dec; 44(12):2516-23. PubMed ID: 9836720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.
    Bazin C; Guinedor A; Barau C; Gozalo C; Grimbert P; Duvoux C; Furlan V; Massias L; Hulin A
    J Pharm Biomed Anal; 2010 Dec; 53(4):997-1002. PubMed ID: 20674215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of renal transplantation using liquid chromatographic monitoring of tacrolimus.
    Borrows R; Chusney G; Loucaidou M; James A; Stichbury J; Van Tromp J; Cairns T; Griffith M; Hakim N; McLean A; Palmer A; Papalois V; Taube D
    Ther Drug Monit; 2006 Apr; 28(2):269-73. PubMed ID: 16628143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low plasma concentrations of albumin influence the affinity column-mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation.
    Tempestilli M; Di Stasio E; Basile MR; Elisei F; Antonini M; Ettorre GM; Iappelli M; Pucillo LP
    Ther Drug Monit; 2013 Feb; 35(1):96-100. PubMed ID: 23191996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of limited sampling strategies for the estimation of mycophenolic acid area under the curve in adult kidney and liver transplant recipients receiving concomitant enteric-coated mycophenolate sodium and tacrolimus.
    Pawinski T; Luszczynska P; Durlik M; Majchrzak J; Baczkowska T; Chrzanowska M; Sobiak J; Glyda M; Kuriata-Kordek M; Kamińska D; Krajewska M; Klinger M
    Ther Drug Monit; 2013 Dec; 35(6):760-9. PubMed ID: 24192641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simplified high-performance liquid chromatography-mass spectrometry assay for measurement of tacrolimus and its metabolites and cross-validation with microparticle enzyme immunoassay.
    Gonschior AK; Christians U; Winkler M; Schiebel HM; Linck A; Sewing KF
    Ther Drug Monit; 1995 Oct; 17(5):504-10. PubMed ID: 8585114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of tacrolimus concentrations in peripheral blood mononuclear cells: application to cardiac transplant recipients.
    Lemaitre F; Antignac M; Fernandez C
    Clin Biochem; 2013 Oct; 46(15):1538-41. PubMed ID: 23454394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An HPLC/MS/MS assay for tacrolimus in patient blood samples. Correlation with results of an ELISA assay.
    Alak AM; Moy S; Cook M; Lizak P; Niggebiugge A; Menard S; Chilton A
    J Pharm Biomed Anal; 1997 Sep; 16(1):7-13. PubMed ID: 9447546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.